Purinergic Signalling in Physiology and Pathophysiology.
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
24 May 2023
24 May 2023
Historique:
received:
17
05
2023
accepted:
19
05
2023
medline:
12
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
Since its inception by the late Geoffrey Burnstock in the early 1970s [...].
Identifiants
pubmed: 37298149
pii: ijms24119196
doi: 10.3390/ijms24119196
pmc: PMC10253113
pii:
doi:
Substances chimiques
Receptors, Purinergic
0
Adenosine Triphosphate
8L70Q75FXE
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Mol Sci. 2022 Oct 05;23(19):
pubmed: 36233136
Int J Mol Sci. 2023 Apr 10;24(8):
pubmed: 37108190
Int J Mol Sci. 2022 Dec 02;23(23):
pubmed: 36499534
Int J Mol Sci. 2022 Jul 17;23(14):
pubmed: 35887215
Int J Mol Sci. 2022 May 20;23(10):
pubmed: 35628550
Int J Mol Sci. 2023 Apr 26;24(9):
pubmed: 37175571
Int J Mol Sci. 2023 Feb 14;24(4):
pubmed: 36835211
Int J Mol Sci. 2022 Feb 08;23(3):
pubmed: 35163829
Int J Mol Sci. 2022 Apr 21;23(9):
pubmed: 35562985
Int J Mol Sci. 2023 Mar 14;24(6):
pubmed: 36982618
Signal Transduct Target Ther. 2021 Apr 28;6(1):162
pubmed: 33907179
Front Pharmacol. 2017 Sep 25;8:661
pubmed: 28993732
Int J Mol Sci. 2022 Nov 28;23(23):
pubmed: 36499200
Int J Mol Sci. 2022 Jul 25;23(15):
pubmed: 35897750
Int J Mol Sci. 2022 Jun 16;23(12):
pubmed: 35743168
Pharmacol Rev. 1972 Sep;24(3):509-81
pubmed: 4404211
Int J Mol Sci. 2022 Jul 14;23(14):
pubmed: 35887132